New Willore Pharma

New Willore Pharma is a commercial-stage pharmaceutical company based in the Philippines that specializes in distributing high-quality, affordable ethical and over-the-counter (OTC) medicines. Founded in 2005 and operational since 2006, the company's comprehensive portfolio spans key therapeutic areas including cardiovascular, gastrointestinal, antibacterial, and allergy care. Its products are exclusively manufactured by Hizon Laboratories, Inc., a pioneer in Philippine pharmaceutical manufacturing with state-of-the-art CGMP-compliant facilities. In October 2024, New Willore Pharma was acquired by New Marketlink Pharmaceutical Corporation (NMPC), a major national healthcare player, enabling the company to expand its reach and enhance healthcare accessibility across the Philippines.